Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
Clinical trial NCT03466294 · COMPLETED
Trial details
- NCT number
- NCT03466294
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2025-01-29
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.